文献速递膀胱癌与上尿路尿路上皮癌

非转移性上尿路尿路上皮癌管理的当前证据与未来展望

Current Evidence and Future Perspectives in the Management of Nonmetastatic Upper Tract Urothelial Carcinoma.
PubMed 文献 · Eur Urol Oncol · 2021-09-22

本文以一名66岁男性无痛性肉眼血尿患者为例,CT发现左肾盂2.5 cm充盈缺损及右近端输尿管狭窄伴肾积水,无淋巴结及转移征象。通过递进式病例讨论,从指南推荐的当前标准治疗和基于最新科学进展的未来视角两方面,探讨非转移性上尿路尿路上皮癌的诊断与治疗选择。

要点

  • CT尿路造影是上尿路尿路上皮癌诊断的关键影像学检查。
  • 非转移性上尿路尿路上皮癌的标准治疗需依据指南推荐。
  • 未来治疗方向可能基于最新科学进展并逐渐成为新标准。

核心结论

  • 病例讨论形式可有效阐述非转移性上尿路尿路上皮癌的当前标准治疗和未来展望。

研究设计与样本

  • 基于病例的讨论:一例66岁男性,因肉眼血尿就诊,尿细胞学良性,CT发现左肾盂2.5 cm充盈缺损及右近端输尿管狭窄伴肾积水,无淋巴结及转移征象,膀胱镜正常。

主要发现

  • CT显示左肾盂2.5 cm充盈缺损和右近端输尿管管腔狭窄伴肾积水,无淋巴结肿大和转移征象。
  • 尿细胞学结果为良性,膀胱镜检查正常。

临床怎么用

  • 临床医生可参考该病例讨论了解非转移性上尿路尿路上皮癌基于指南的当前标准治疗及未来发展方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This case-based discussion describes the management of a 66-yr-old man who presented to the emergency department with gross hematuria. His urine cytology was benign, and computed tomography (CT) with nephrographic phase revealed a 2.5 cm filling defect within the left renal pelvis and luminal narrowing in the right proximal ureter with hydronephrosis. CT showed no lymphadenopathy and no sign of metastatic disease. Cystoscopy was normal. In a progressive case-based discussion fashion, we will discuss the diagnostic and treatment options with two different perspectives: (1) guidelines-based current standard of care and (2) an outlook on future perspectives using the latest scientific advances that may soon become the standard of care. PATIENT SUMMARY: This presentation of a real-life clinical scenario will be useful in describing the current standard of care and future perspectives regarding the diagnosis and treatment of upper urinary tract tumors.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Lenfant L, Breda A, Xylinas E, et al. Current Evidence and Future Perspectives in the Management of Nonmetastatic Upper Tract Urothelial Carcinoma. Eur Urol Oncol. 2021. PMID: 34561205. doi:10.1016/j.euo.2021.09.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。